Senores Pharmaceuticals Ltd
Senores Pharma. | 544319
Share Price Chart - Senores Pharmaceuticals Ltd
Stock Performance
Ratios
About Company
- Senores Pharmaceuticals Limited was originally incorporated as 'Senores Pharmaceuticals Private Limited' through a Certificate of Incorporation dated December 26, 2017, issued by the Registrar of Companies, Central Registration Centre
- Thereafter, the name of the Company was changed to 'Senores Pharmaceuticals Limited' upon conversion to a Public Limited Company and a fresh Certificate of Incorporation dated September 4, 2023, was issued by the RoC to the Company
- Senores Pharma is a global research driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products predominantly for Regulated Markets across various therapeutic areas and dosage forms
- The Regulated Markets business is focused on Regulated Markets of US and Canada
- The Company has adopted a strategy of identifying, developing and commercializing specialty and complex niche products in the mid-market range and received approvals for 19 ANDAs
- Further, it develop and manufacture pharmaceutical products across various therapeutic areas for Emerging Markets, having a presence across 43 countries
- The Company operate a Critical Care Injectables Business, supplying critical care injectables to hospitals across India through distributors, and manufacture APIs for the domestic market and SAARC countries
- In 2021, the Company incorporated a wholly owned subsidiary, Senores Pharmaceuticals Inc in the US
- It then entered the new segment of API by acquiring Ratnagene Lifescience Private Limited
- The Company started domestic business with the launch of the Critical Care Injectables Business in 2022
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *
Top Gainers
Frequently Asked Questions
What is Share Price of Senores Pharmaceuticals Ltd?
The current share price of Senores Pharmaceuticals Ltd (Senores Pharma.) is ₹1417.80. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Senores Pharmaceuticals Ltd?
The Price-to-Earnings (P/E) ratio of Senores Pharmaceuticals Ltd is 1417.80. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Senores Pharmaceuticals Ltd?
Senores Pharmaceuticals Ltd has a 52-week high of ₹1487.90 and a 52-week low of ₹575.65. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Senores Pharmaceuticals Ltd?
Senores Pharmaceuticals Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Senores Pharmaceuticals Ltd?
The Earnings Per Share (EPS) of Senores Pharmaceuticals Ltd is ₹25.05. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Senores Pharmaceuticals Ltd?
Senores Pharmaceuticals Ltd has a Return on Equity (ROE) of 0.84%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
